During the past two decades several investigators have sought to determine the role, if any, of defective fibrinolysis in the pathogenesis of myocardial infarction and coronary artery disease. While some of them (Hume, 1958; Ogston, 1962; Chakrabarti et al., 1966 Chakrabarti et al., , 1968 Bick et al., 1972; Svehla, 1973; Bruhn et al., 1974) found that there was reduced fibrinolytic activity in the blood of patients with recent or old myocardial infarction, and attributed to it a significant role in the course of coronary artery disease, others (Merskey et al., 1960; Naimi et al., 1963; Katz et al., 1963) found no significantly different fibrinolysis in these patients when compared with normal controls. The majority of papers report the results of random samples, without regard to the time after infarction, and without considering the various components of the fibrinolytic system separately. The purpose of the present investigation was to determine systematically the level of fibrinolytic activity of plasma during the period after an acute myocardial infarct, and to analyse the behaviour of several components of the fibrinolytic system during this period.
Patients and methods
Fibrinolytic activity of plasma was determined in 42 patients with acute myocardial infarction, aged 42 to 75 years. The diagnosis was established by strict clinical, electrocardiographic, and enzymatic criteria. The fibrinolytic activity was determined by two methods on days, 1, 2, 4, 5, 6, 8, 10, 14, and 17 after the acute episode; the blood was drawn, with Received for publication 14 June 1976 little or no venous compression, between 8 and 9 a.m. from the fasting patients. In 29 of these patients the level of fibrinogen was determined at the same time; in 10 patients the plasminogen level and in 5 the level of antiplasmin.
In 24 of these patients the fibrinolytic activity was determined again 12 to 15 months after the acute infarction.
Methods
(1) Dilute blood clot lysis time (DBCLT) (Fearnley et al., 1957) . The end-point was determined photographically; the normal range in 35 agematched controls was, in our laboratory, 3 9 ±1-05 hours.
(2) Streptokinase-activated lysis time (SALT) (Gidron et al., to be published). 1 ml citrated blood is centrifuged and 0'1 ml plasma is diluted with 0X8 ml phosphate buffer (0X15 molar, pH 7.4). 3 U of streptokinase (Varidase, Lederle) is added to the diluted plasma, resulting in a concentration corresponding to 30 U/ml plasma, followed by 10 U thrombin (Upjohn There was a consistent and significant temporary reduction of fibrinolytic activity in all the patients 7- with acute myocardial infarction during the first week.
The lysis time increased progressively, as measured by both methods, until the 4th or 5th day after the infarction, with a gradual return to initial levels or below during the following days. In 35 patients (83 3%) the maximal reduction of fibrinolytic activity was found by both methods on the same day; in 7 patients (16.7%) there was a divergence by 1 to 2 days.
(a) Dilute blood clot lysis time ( Fig. 1) The prolongation of the lysis time was significant at its peak (P < 0 05) as compared with the values on day 1 after infarction, as well as those of normal controls. The lysis time determined by this method after day 13 was significantly lower than on day 1. day 1 till the end of the acute phase (P < 0 05). The maximum prolongation on day 4 or 5 was highly significant both in relation to normal controls and to day 1 (P<O0001 (FIG. 4) The level of plasminogen rose gradually and the increase was significant from day 5 onwards and reaching a flat peak from days 8 to 10 (P < 0 05).
After that there was a gradual decline.
4. ANTIPLASMIN (FIG. 5) The level of these inhibitors rose in the 5 cases in which it was determined on the days after infarction and reached its peak on day 6, paralleling the re- fibrinogen and plasminogen levels, both the latter being more prolonged.
6. In 2 patients excess fibrinogen and plasminogen were added to the plasma before activation with streptokinase. Fig. 7 shows that nevertheless a delay in lysis time by the SALT method occurs on day 5 after infarction. activity (SALT) and fibrinogen level were determined. The mean value for lysis time was 6-75 ± 1-28 min, which was not significantly different from normal values (P >0 05) while the mean fibrinogen level was 2-9 g/l.
8. The Table summarises the results of both lysis tests on day 1, on the day of maximum inhibition of fibrinolysis and on day 10 after infarction, as well as the streptokinase activated lysis time in the patients re-examined after 12 to 15 months.
Discussion
The above results leave little doubt that there is a significant reduction of fibrinolytic activity in the plasma of patients during the first week after an acute myocardial infarction. This reduction, which reaches its maximum 4 to 5 days after the event, is apparently independent of the availability of activators, since it is also evident in the streptokinase activated clot lysis, where an excess of extrinsic activator is supplied. The rise of fibrinogen level is much more prolonged and it remains high after the lysis time approaches normal levels. It may be argued, however, that the higher level of plasminogen on days 5 to 8 counteracts the influence of fibrinogen on lysis with a return of fibrinolytic activity to normal levels. To clarify this point two additional patients were examined by the SALT method, with addition of excess plasminogen and fibrinogen to the plasma. The results (Fig. 7) showed a similar pattern to that obtained in other patients, with a somewhat longer initial lysis time on day 1 and a significant delay on day 5. This seems to exclude a predominant role of fibrinogen and plasminogen in the observed changes in fibrinolysis on day 5, suggesting that the remaining factors in the fibrinolytic system-the inhibitors-cause this delay. The level of inhibitors showed a rise and fall which paralleled the delay in lysis time in all the cases in which it was determined, and so appears to be the main factor responsible for the temporarily diminished fibrinolytic activity in subjects after acute myocardial infarction.
One may speculate that there is a transient increase in fibrinolytic activity caused by increased activation immediately after an acute infarction, and that the rise in fibrinogen level as well as that of the inhibitors is a reaction to this increased activity. This assumption will be confirmed or refuted when more sensitive methods for the determination of activators of fibrinolysis become available.
The observation that the fibrinolytic activity was found not to be significantly different from normal in the 24 patients re-examined 12 to 15 months after the infarction seems to indicate that the defective fibrinolysis is a transient phenomenon after myocardial infarction rather than a causative factor involved in the pathogenesis of this disease.
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